BIOLOGIC RESPONSE MODIFIERS IN PEDRIATIC CANCER
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference103 articles.
1. Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders;Ackerstein;Blood,1991
2. Immune adjuvants;Akporiaye,1995
3. Phase I evaluation of intravenous recombinant human IL-12 in patients with advanced malignancies;Atkins;Clin Cancer Res,1997
4. Pilot study of subcutaneous human recombinant interleukin-12 in metastatic melanoma;Bajetta;Clin Cancer Res,1998
5. A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma: A Children's Cancer Group Study;Bauer;Cancer,1995
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies for Using Muramyl Peptides - Modulators of Innate Immunity of Bacterial Origin - in Medicine;Frontiers in Immunology;2021-04-20
2. Pediatric surgical oncology: A brief overview of where we have been and the challenges we face;Seminars in Pediatric Surgery;2019-12
3. Chemotherapy and Novel Cancer Targeted Therapies;The Surgery of Childhood Tumors;2016
4. Epidemiology of Infections in Cancer Patients;Infectious Complications in Cancer Patients;2014
5. PRINCIPLES OF ADJUVANT THERAPY IN CHILDHOOD CANCER;Ashcraft's Pediatric Surgery;2010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3